Benuvia Manufacturing, a developer and manufacturer of high-purity synthetic pharmaceutical grade cannabinoids, has named Scott Watson as its new vice president, head of Commercial Operations, it was reported on Wednesday.
Watson has more than twenty-five years of experience in the pharmaceutical and biotechnology industries. In the new role, he will be responsible for all business development, sales, and marketing.
Prior to joining Benuvia Manufacturing, Watson held senior operational and sales leadership positions at Thermo Fisher Scientific, Ampac Fine Chemicals and Durect Corporation. He has served as a professor and adjunct professor at the University of Alabama at Birmingham (Collat School of Business) since 2000.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar